6505--762-25-1-040-0304 -Tucson CMOP PROPRANOLOL -(VA-25-00021631)

The Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network 15, is seeking to procure two pharmaceutical products through a small business set-aside Request for Quote (RFQ). The procurement involves obtaining 960 bottles of Propranolol HCL 60mg SA capsules and 11,520 bottles of Propranolol HCL 10mg tablets for delivery to the VA Consolidated Mail Outpatient Pharmacy (CMOP) facility in Tucson, Arizona. Potential vendors must submit a comprehensive package including a signed SF1449 solicitation cover page, an Excel format price schedule, a valid State Wholesale Distributor License, and a Buy American Act (BAA) Certificate specifying the country of origin. The RFQ (36C77025Q0137) requires vendors to demonstrate compliance with specific documentation requirements, with failure to provide a valid State Wholesale Distributor License resulting in non-compliance. The estimated solicitation issue date is March 7, 2025, with responses due by March 14, 2025, and all submissions must be emailed to lacie.nowak@va.gov.

The contract is exclusively set aside for small businesses within the Pharmaceutical Preparation Manufacturing (NAICS 325412) category, with a product service code of 6505 for Drugs and Biologicals. The delivery timeframe is specified as 10 days after receipt of order, indicating a relatively quick turnaround expectation for the selected vendor. While specific award values are not disclosed, the procurement involves precise quantities of pharmaceutical products totaling 12,480 bottles across two medication strengths. Vendors must be prepared to provide comprehensive documentation demonstrating their ability to meet the VA's stringent requirements, including a current state wholesale distributor license and compliance with the Buy American Act. The solicitation emphasizes the importance of precise, concise responses that directly address the outlined requirements, with the expectation that all submitted documentation will be thoroughly reviewed for compliance and suitability.